Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-26 Sale | 2025-03-26 8:10 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 1,095 | $17.05 | $18,670 | 56,363 (Direct) | View |
| 2025-03-26 Sale | 2025-03-26 8:06 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 3,171 | $17.05 | $54,066 | 218,738 (Direct) | View |
| 2025-03-05 Sale | 2025-03-06 6:30 pm | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 4,919 | $18.23 | $89,673 | 17,595 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 6:48 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 475 | $19.96 | $9,481 | 20,228 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 6:46 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 773 | $19.96 | $15,429 | 53,882 (Direct) | View |
| 2024-11-19 Sale | 2024-11-19 8:43 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 10,329 | $16.81 | $173,630 | 81,931 (Direct) | View |
| 2024-11-19 Sale | 2024-11-19 8:41 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 4,073 | $16.81 | $68,467 | 27,795 (Direct) | View |
| 2024-11-19 Sale | 2024-11-19 8:40 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 10,259 | $16.81 | $172,454 | 73,128 (Direct) | View |
| 2024-08-19 Sale | 2024-08-20 6:46 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 9,733 | $15.28 | $148,720 | 43,735 (Direct) | View |
| 2024-08-19 Sale | 2024-08-20 6:43 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 9,534 | $15.28 | $145,680 | 52,177 (Direct) | View |
| 2024-08-19 Sale | 2024-08-20 6:40 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 31,747 | $15.28 | $485,094 | 186,555 (Direct) | View |
| 2024-06-10 Sale | 2024-06-11 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 975 | $14.79 | $14,420 | 34,564 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 3,503 | $16.94 | $59,341 | 52,498 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 3,477 | $16.94 | $58,900 | 62,578 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 1,326 | $16.94 | $22,462 | 22,158 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 11,427 | $16.94 | $193,573 | 222,404 (Direct) | View |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 26,574 | $17.87 | $474,877 | 317,600 (Direct) | View |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2,568 | $17.87 | $45,890 | 48,844 (Direct) | View |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 1,790 | $17.87 | $31,987 | 17,120 (Direct) | View |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2,716 | $17.87 | $48,535 | 39,293 (Direct) | View |
| 2024-03-27 Sale | 2024-03-27 8:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 5,140 | $17.9 | $92,006 | 153,316 (Direct) | View |
| 2024-03-27 Sale | 2024-03-27 7:58 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 17,714 | $17.9 | $317,081 | 405,293 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-25 Exercise | 2025-03-26 8:10 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 2,142 | $0 | 56,363 (Direct) | View |
| 2025-03-24 Option Award | 2025-03-26 8:10 pm | N/A 2035-03-23 | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 28,662 | $0 | 56,363 (Direct) | View |
| 2025-03-25 Exercise | 2025-03-26 8:06 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 6,178 | $0 | 218,738 (Direct) | View |
| 2025-03-24 Option Award | 2025-03-26 8:06 pm | N/A 2035-03-23 | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 143,313 | $0 | 218,738 (Direct) | View |
| 2025-03-24 Option Award | 2025-03-26 8:03 pm | N/A 2035-03-23 | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 132,351 | $0 | 133,371 (Direct) | View |
| 2025-03-24 Option Award | 2025-03-26 7:52 pm | N/A 2035-03-23 | ACADIA PHARMACEUTICALS INC | ACAD | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 118,256 | $0 | 118,256 (Direct) | View |
| 2025-03-24 Option Award | 2025-03-26 7:49 pm | N/A 2035-03-23 | ACADIA PHARMACEUTICALS INC | ACAD | Owen Adams Catherine Chief Executive Officer | 414,015 | $0 | 414,015 (Direct) | View |
| 2025-02-23 Exercise | 2025-02-25 6:48 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 840 | $0 | 20,228 (Direct) | View |
| 2025-02-23 Exercise | 2025-02-25 6:46 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 1,353 | $0 | 53,882 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-10 6:33 pm | N/A 2034-12-08 | ACADIA PHARMACEUTICALS INC | ACAD | Garner Thomas EVP, Chief Commercial Officer | 281,221 | $0 | 281,221 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 8:43 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 19,826 | $0 | 81,931 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 8:41 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 7,930 | $0 | 27,795 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 8:40 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 19,826 | $0 | 73,128 (Direct) | View |
| 2024-10-12 Exercise | 2024-10-15 6:05 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 4,381 | $0 | 15,414 (Direct) | View |
| 2024-09-23 Option Award | 2024-09-25 6:53 pm | N/A 2034-09-22 | ACADIA PHARMACEUTICALS INC | ACAD | Adams Catherine Owen Chief Executive Officer | 353,261 | $0 | 353,261 (Direct) | View |
| 2024-08-16 Option Award | 2024-08-20 6:46 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 18,904 | $0 | 43,735 (Direct) | View |
| 2024-08-16 Option Award | 2024-08-20 6:43 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 18,653 | $0 | 52,177 (Direct) | View |
| 2024-08-16 Option Award | 2024-08-20 6:40 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 62,115 | $0 | 186,555 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-13 6:05 pm | N/A 2034-08-11 | ACADIA PHARMACEUTICALS INC | ACAD | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 389,126 | $0 | 389,126 (Direct) | View |
| 2024-06-08 Exercise | 2024-06-11 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 1,893 | $0 | 34,564 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 6,652 | $0 | 36,379 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 25,346 | $0 | 36,379 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 6,652 | $0 | 47,860 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 25,346 | $0 | 47,860 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 6,652 | $0 | 50,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 25,346 | $0 | 50,000 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director | 6,652 | $0 | 51,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director | 25,346 | $0 | 51,000 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director | 6,652 | $0 | 60,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director | 25,346 | $0 | 60,000 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 6,652 | $0 | 45,500 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 25,346 | $0 | 45,500 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 4:10 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 82,610 | $0 | 39,619,339 (Indirect) | View |
| 2024-05-01 Exercise | 2024-05-03 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 6,814 | $0 | 52,498 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 6,814 | $0 | 62,578 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 2,596 | $0 | 22,158 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 22,391 | $0 | 222,404 (Direct) | View |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 51,999 | $0 | 317,600 (Direct) | View |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 5,024 | $0 | 48,844 (Direct) | View |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 3,499 | $0 | 17,120 (Direct) | View |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 5,275 | $0 | 39,293 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 8:02 pm | N/A 2034-03-24 | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 22,532 | $0 | 22,532 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 8:00 pm | N/A 2034-03-24 | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 127,024 | $0 | 153,316 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 7:58 pm | N/A 2034-03-24 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 321,117 | $0 | 405,293 (Direct) | View |